Blockchain Registration Transaction Record

HeartBeam Completes Heart Attack Detection Study Enrollment Ahead of Schedule

HeartBeam completes ALIGN-ACS pilot study enrollment for heart attack detection using 3D ECG technology. Results to support FDA discussions for expanded indication. Read more.

This news matters because heart attacks are a leading cause of death worldwide, and current detection methods often require bulky equipment or delayed diagnosis. HeartBeam's 3D ECG technology, if approved for heart attack detection, could enable rapid, portable, and accurate diagnosis outside of clinical settings, potentially saving lives by reducing time to treatment. The accelerated enrollment suggests strong clinical interest and could speed up regulatory approval, bringing this life-saving technology to patients sooner.